Behavioral pharmacology of σ-ligands

Pharmacopsychiatry

Volumn 37, Issue SUPPL. 3, 2004, Pages

  Skuza, Grazyna ^a   Wedzony K ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

1 (3 CHLORO 4 CYCLOHEXYLPHENYL) 3 (HEXAHYDRO 1 AZEPINYL)PROPENE; 1 (3,4 DIMETHOXYPHENETHYL) 4 (3 PHENYLPROPYL)PIPERAZINE; 1,3 BIS(2 METHYLPHENYL)GUANIDINE; 2 [4 METHOXY 3 (2 PHENYLETHOXY)PHENYL] N,N DIPROPYLETHYLAMINE; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 (4 FLUOROPHENYL) 1,2,3,6 TETRAHYDRO 1 [4 (1,2,4 TRIAZOL 1 YL)BUTYL]PYRIDINE; 4 PHOSPHONOMETHYLPIPECOLIC ACID; 6 [6 (4 HYDROXY 1 PIPERIDINYL)HEXYLOXY] 3 METHYLFLAVONE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ALPHA (4 FLUOROPHENYL) 4 (5 FLUORO 2 PYRIMIDINYL) 1 PIPERAZINEBUTANOL; ATYPICAL ANTIPSYCHOTIC AGENT; BD 1063; CLOZAPINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; ELIPRODIL; HALOPERIDOL; IFENPRODIL; IGMESINE; MS 377; N [2 (2,3 DICHLOROPHENYL)ETHYL] 2 DIMETHYLAMINO N METHYLETHYLAMINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N ALLYLNORMETAZOCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NALOXONE; NEUROLEPTIC AGENT; OPC 14523; OPIATE RECEPTOR; PENTAZOCINE; PHENCYCLIDINE; RIMCAZOLE; SEROTONIN 1A AGONIST; SIGMA 1 OPIATE RECEPTOR; SIGMA 2 OPIATE RECEPTOR; SIGMA RECEPTOR LIGAND; SULPIRIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

BEHAVIOR; CONFERENCE PAPER; DOPAMINERGIC SYSTEM; DRUG BINDING SITE; MOOD DISORDER; MOTOR DYSFUNCTION; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PSYCHOSIS; SCHIZOPHRENIA;

AMNESIA; ANIMALS; ANTIDEPRESSIVE AGENTS; CINNAMATES; COCAINE-RELATED DISORDERS; CYCLOPROPANES; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; HUMANS; HYPERICUM; LIGANDS; NOOTROPIC AGENTS; PIPERAZINES; PLANT EXTRACTS; PSYCHOPHARMACOLOGY; PSYCHOTIC DISORDERS; QUINOLONES; RECEPTORS, SIGMA; STEROIDS;

EID: 9644264404     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-832676     Document Type: Conference Paper

References (64)

1. Akunne HC, Zoski KT, Whetzel SZ, Cordon JJ, Brandon RM, Roman F, Pugsley TA. Neuropharmacological profile of a selective σ ligand, igmesine: a potential antidepressant. Neuropharmacology 2001; 41: 138-149
2. Bastianetto S, Perrault G, Sanger DJ. Pharmacological evidence for the involvement of σ sites in DTG-induced contralateral circling in rats. Neuropharmacology 1995; 34: 107-114
3. Bermack J, Lavoie N, Dryver E, Debonnel G. Effects of sigma ligands on NMDA receptor function in the bulbectomy model of depression: a behavioural study in the rat. Int J Neuropsychopharmacol 2002; 5: 53-62
4. Bristow LJ, Baucutt L, Thorn L, Huston PH, Noble A, Beer M, Middlemiss DN, Tricklebank MD. Behavioural and biochemical evidence of the interaction of the putative antipsychotic agent, BMY 14802 with the 5-HT1A receptor. Eur J Pharmacol 1991; 4: 21-28
5. Clissold DB, Pontecorvo MJ, Jones BE, Abreu ME, Karbon EW, Erickson RH, Natalie KJ, Jr, Borosky S, Hartman T, Mansbach RS, Balster RL, Ferkany JW, Enna SJ. NPC 16377, a potent and selective σ ligand. II. Behavioral and neuroprotective profile. J Pharmacol Exp Ther 1993; 265: 876-886
6. Debonnel G, de Montigny C. Modulation of NMDA and dopaminergic neurotransmissions by sigma ligands: possible implications for the treatment of psychiatric disorders. Life Sci 1996; 58: 721-734
7. Dziedzicka-Wasylewska M, Rogoz R, Klimek V, Maj J. Repeated administration of antidepressant drugs affects the level of mRNA coding for D1 and D2 dopamine receptors in the rat brain. J Neural Transm 1997; 104: 515-524
8. Ferris RM, Harfenist M, McKenzie GM, Cooper B, Soroko FE, Maxwell SA. BW 234U, (cis-9-[3-(3,5-dimethyl-1-piperazinyl)propyl] carbazole dihydrochloride): a novel antipsychotic agent. J Pharm Pharmacol 1982; 34: 388-390
9. Goldstein SR, Matsumoto RR, Thompson TL, Patrick RL, Bowen WD, Walker JM. Motor effects of two σ ligands mediated by nigrostriatal neurons. Synapse 1989; 4: 254-258
10. Gudelsky GA. Biphasic effect of sigma receptor ligands on the extracellular concentration of dopamine in the striatum of the rat. J Neural Transm 1999; 106: 849-856
11. Guitart X, Codony X, Ballarin M, Dordal A, Farré AJ. E-5842: A new potent and preferential sigma ligand. Preclinical pharmacological proile. CNS Drug Rev 1998; 4: 201-224
12. Huber MT, Gotthardt U, Schreiber W, Krieg JC. Efficacy of the σ receptor ligand EMD 57445 (panamesine) in patients with schizophrenia: an open clinical trial. Pharmacopsychiatry 1999; 32: 68-72
13. Ishiguro H, Otsuki T, Toru M, Itokawa M, Aoki J, Shibuya H, Kurumaji A, Okubo Y, Iwawaki A, Ota K, Shimizu H, Hamaguchi H, Arinami T. Association between polymorphisms in the type 1 sigma receptor gene and schizophrenia. Neurosci Lett 1998; 257: 45-48
14. Itzhak Y, Kassim CO. Clorgyline displays high affinity for σ sites in C57-BL/6 mouse brain. Eur J Pharmacol 1990; 176: 107-108
15. 1 sites. Eur J Pharmacol 1996; 299: 21-28
16. Kizu A, Yoshida Y, Miyagishi T. Rat cortical sigma receptors differentially regulated by pentazocine and haloperidol. J Neural Transm (Gen Sect) 1991; 83: 149-153
17. 1 Receptor subtype is involved in the facilitation of cortical dopaminergic transmission in the rat brain. Neurochem Res 1997; 22: 1105-1109
18. Kornhuber J, Schoppmeyer K, Riderer P. Affinity of 1-aminoadamantanes for the sigma binding site in postmortem human frontal cortex. Neurosci Lett 1993; 163: 129-131
19. 2 binding in rat brain. Eur J Pharmacol 1994; 259: 65-69
20. 3 receptors in the rat brain. Eur J Pharmacol 1998; 351: 31-37
21. 2 agonist. J Neural Transm-Gen Sect 1989; 78: 1-8
22. Maj J, Rogóz Z, Skuza G, Mazela H. Neuropharmacological profile of EMD 57445, a σ receptor ligand with potential antipsychotic activity. Eur J Pharmacol 1996; 315: 235-243
23. Martin WR, Eades CG, Thompson JA, Huppler E, Gilbert PE. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 1976; 197: 517-532
24. Matsumoto RR, Bowen WD, Tom MA, Vo VN, Truong DD, De Costa BR. Characterization of two novel σ receptor ligands: antidystonic effects in rats suggest σ receptor antagonism. Eur J Pharmacol 1995; 280: 301-310
25. 1 receptors produce anti-cocaine effects in mice. Eur J Pharmacol 2001; 419: 163-174
26. 1 Receptor subtype is involved in the relief of behavioral despair in the mouse forced swimming test. Eur J Pharmacol 1996; 312: 267-271
27. Matsuno K, Senda K, Matsunaga K, Mita S. Ameliorating effects of σ receptor ligands on the impairment of passive avoidance tasks in mice: involvement in the central acetylcholinergic system. Eur J Pharmacol 1994; 261: 43-51
28. Maurice T, Hiramatsu M, Itoh J, Kameyama T, Hasegawa T, Nabeshima T. Behavioral evidence for a modulating role of σ ligands in memory processes. I. Attenuation of dizocilpine (MK-801)-induced amnesia. Brain Res 1994; 647: 44-56
29. 1 receptor agonist properties, facilitates NMDA receptor-dependent learning in mice. Eur J Pharmacol 1997; 328: 9-18
30. Melzer LT, Christoffersen CL, Serpa KA, Pugsley TA, Razmpour A, Heffner TG. Lack of involvement of haloperidol-sensitive σ bindindg sites in modulation of dopamine neuronal activity and induction of dystonias by antipsychotic drugs. Neuropharmacology, 1992; 31: 961-967
31. Menkel M, Terry P, Pontecorvo M, Katz JL, Witkin JM. Selective σ ligands block stimulant effects of cocaine. Eur J Pharmacol 1999; 201: 251-252
32. 1 receptor agonist SA4503 significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological studies. Synapse 1999; 33: 129-140
33. Ogawa S, Okuyama S, Tsuchida K, Araki H, Otomo S. The sigma-selective ligand NE-100 attenuates the effect of phencyclidine in a rat diving model. Gen Pharmacol 1995; 26: 177-182
34. Okuyama S, Imagawa Y, Ogawa S, Araki H, Ajima A, Tanaka M, Muramatsu M, Nakazato A, Yamaguchi K, Yoshida M. NE-100, novel σ receptor ligand: in vivo tests. Life Sci 1993; 43: PL285-290
35. Patrick SL, Walker JM, Lockwood M, Patrick RL. Increases in striatal extracellular dopamine and vacuous chewing produced by two σ receptor ligands. Eur J Pharmacol 1993; 231: 243-249
36. 2 extract of Hypericum perforatum on alcohol intake in rats. Alcohol Alcohol 2001; 36: 199-206
37. Poncelet M, Santucci V, Paul R, Gueudet C, Lavastre S, Guitard J, Steinberg R, Terranova JP, Blière JC, Soubrié P, Le Fur G. Neuropharmacological profile of a novel and selective ligand of the sigma site: SR 31742A. Neuropharmacology 1993; 32: 605-615
38. 1 sites. Trends Pharmacol Sci 1992; 13: 85-86
39. Raffa R. Screen of receptor and uptake-site activity of hypericin component of St John's wort receptor binding. Life Sci 1998; 62: 265-270
40. 1) receptor mediated antidepressant-like effects of neurosteroids in the Porsolt forced swim test. NeuroReport 1998; 9: 3069-3073
41. 1 receptor in the cocaine-induced conditioned place preference. Neuroreport 2000; 11: 2885-2888
42. 2 ligand Lu 28-179 has potent anxiolytic-like effects in rodents. J Pharmacol Exp Ther 1997; 283: 1323-1332
43. Sánchez C, Meier E. Behavioural profile of SSRIs in animal models of depression, anxiety and aggression. Are they all alike. Pychopharmacology 1997; 129: 197-205
44. 2 ligand Lu 28-179 has an antidepressant-like profile in the rat chronic mild stress model of depression. Behav Pharmacol 2000; 11: 117-124
45. 3H]3-PPP binding to σ sites in rat brain. Eur J Pharmacol 1989; 165: 335-336
46. 1 receptor agonist, on memory impairments induced by cholinergic dysfunction in rats. Eur J Pharmacol 1996; 315: 1-10
47. Shirayama Y, Nishikawa T, Umino A, Takahasi K. p-Chlorophenylalanine- reversible reduction of σ binding sites by chronic imipramine treatment in rat brain. Eur J Pharmacol 1993; 237: 117-126
48. Skolnick P. Antidepressants for the new millennium. Eur J Pharmacol 1999; 375: 31-40
49. Skuza G. Effect of sigma ligands on the cocaine-induced convulsions in mice. Pol J Pharmacol 1999; 51: 477-483
50. 1- adrenergic system. A behavioral study. Pol J Pharmacol 2001; 53: 547-550
51. Skuza G, Rogóz Z. Effect of 1 3-di-o-tolylguanidine (DTG), rimcazole and EMD 57445, the σ receptor ligands, in the forced swimming test. Pol J Pharmacol 1997; 49: 329-335
52. 1 receptor agonist. Behav. Pharmacol 2002; 13: 537-543
53. Skuza G, Rogóz Z. Effect of combined treatment with selective σ ligands and amantadine in the forced swimming test in rats. Pol J Pharmacol 2002; 54: 699-702
54. 1 receptor antagonists attenuate antidepressant-like effect induced by co-administration of 1,3 di-o-tolylguanidine (DTG) and memantine in the forced swimming test in rats. Pol J Pharmacol 2003; 55: 1149-1152
55. Takahashi S, Sonehara K, Takagi K, Miwa T, Horikomi K, Mita N, Nagase H, Iizuka K, Sakai K. Pharmacological profile of MS-377, a novel antipsychotic agents with selective affinity for sigma receptors. Psychopharmacology (Berl.) 1999; 145: 295-302
56. 1A receptor agonist OPC-14523. Neuropharmacology 2001; 41: 976-988
57. Tran TT, de Costa B, Matsumoto RR. Microinjection of sigma ligands into cranial nerve nuclei produces vacuous chewing in rats. Psychopharmacology 1998; 137: 191-200
58. Ukai M, Maeda H, Nanya Y, Kameyama T, Matsuno K. Beneficial effects of acute and repeated administrations of σ receptor agonists on behavioral despair in mice exposed to tail suspension. Pharmacol Biochem Behav 1998; 61: 247-253
59. Urani A, Roman FJ, Phan VL, Maurice T. The antidepressant-like effect induced by σ receptor agonists and neuroactive steroids in mice submitted to the forced swimming test. J Pharmacol Exp Ther 2001; 298: 1269-1279
60. Walker JM, Bowen WD, Walker FO, Matsumoto RR, De Costa B, Rice KC. Sigma receptors: biology and function. Pharmacol Rev 1990; 42: 355-402
61. 2 receptors in motor function. Eur J Pharmacol 1993; 231: 61-68
62. Witkin JM, Terry P, Menkel M, Mickey P, Pontecorvo M, Ferkany J, Katz JL. Effects of the selective sigma receptor ligand, 6-[6-(4-hydroxypiperidinyl) hexyloxy]-3-methylflavone (NPC 16377), on behavioral and toxic effects of cocaine. J Pharmacol Exp Ther 1993; 266: 473-482
63. 1 receptor ligand, MS-377 on apomorphine- or phencyclidine-induced disruption of prepulse inhibition of acoustic startle in rats. Eur J Pharmacol 2000; 402: 251-254
64. Zou L-B, Yamada K, Nabeshima T. σ Receptor ligands (+)-SKF10,047 and SA4503 improve dizocilpine-induced spatial memory deficits in rats. Eur J Pharmacol 1998; 355: 1-10